BA
IRWD icon

BlackRock Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

BlackRock Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6.5M Buy
507,288
+112,261
+28% +$1.42M 0.01% 1039
2016
Q3 		$5.25M Buy
395,027
+29,780
+8% +$348K 0.01% 1109
2016
Q2 		$4M Buy
365,247
+7,249
+2% +$70.8K ﹤0.01% 1193
2016
Q1 		$3.28M Buy
357,998
+207,399
+138% +$1.71M ﹤0.01% 1249
2015
Q4 		$1.46M Sell
150,599
-76,053
-34% -$735K ﹤0.01% 1542
2015
Q3 		$1.98M Buy
226,652
+40,749
+22% +$380K ﹤0.01% 1365
2015
Q2 		$1.88M Buy
185,903
+50,825
+38% +$591K ﹤0.01% 1302
2015
Q1 		$1.81M Buy
135,078
+17,818
+15% +$234K ﹤0.01% 1265
2014
Q4 		$1.5M Sell
117,260
-5,429
-4% -$62.1K ﹤0.01% 1311
2014
Q3 		$1.33M Sell
122,689
-10,787
-8% -$123K ﹤0.01% 1308
2014
Q2 		$1.71M Sell
133,476
-12,699
-9% -$138K ﹤0.01% 1218
2014
Q1 		$1.51M Sell
146,175
-187,240
-56% -$2.11M ﹤0.01% 1296
2013
Q4 		$3.24M Buy
333,415
+6,126
+2% +$55K ﹤0.01% 1068
2013
Q3 		$3.25M Sell
327,289
-214,381
-40% -$2.1M ﹤0.01% 1065
2013
Q2 		$4.5M Buy
+541,670
New +$6.57M ﹤0.01% 982

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors's IRWD Position: Q4 2016 in Review

BlackRock Advisors increased its Ironwood Pharmaceuticals (IRWD) stake by 28% in Q4 2016, buying an estimated $1.42M and bringing the position to 507,288 shares worth $6.5M. The position accounts for 0.01% of the portfolio, ranked #1039.

BlackRock Advisors first reported a position in IRWD in Q2 2013 and has held it in 15 quarters since. 163 funds tracked by Wall St. Rank hold IRWD as of Q4 2016.

  • BlackRock Advisors held 507,288 shares of Ironwood Pharmaceuticals worth $6.5M as of Q4 2016.
  • BlackRock Advisors bought 112,261 Ironwood Pharmaceuticals shares in Q4 2016, an estimated $1.42M.
  • Ironwood Pharmaceuticals made up 0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1039 holding.
  • BlackRock Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • 163 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.